JP2021533166A5 - - Google Patents
Info
- Publication number
- JP2021533166A5 JP2021533166A5 JP2021506492A JP2021506492A JP2021533166A5 JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5 JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- target ligand
- car
- payload drug
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862715666P | 2018-08-07 | 2018-08-07 | |
| US62/715,666 | 2018-08-07 | ||
| PCT/US2019/042726 WO2020033129A1 (en) | 2018-08-07 | 2019-07-21 | Rejuvenation of car t cell |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533166A JP2021533166A (ja) | 2021-12-02 |
| JP2021533166A5 true JP2021533166A5 (enExample) | 2022-07-28 |
| JP7623935B2 JP7623935B2 (ja) | 2025-01-29 |
Family
ID=69415080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506492A Active JP7623935B2 (ja) | 2018-08-07 | 2019-07-21 | Ｃａｒ ｔ細胞の若返り |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210308267A1 (enExample) |
| EP (1) | EP3833400A4 (enExample) |
| JP (1) | JP7623935B2 (enExample) |
| KR (1) | KR20210042125A (enExample) |
| CN (2) | CN112543651B (enExample) |
| AU (1) | AU2019317278B2 (enExample) |
| CA (1) | CA3108710A1 (enExample) |
| SG (1) | SG11202100616VA (enExample) |
| WO (1) | WO2020033129A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| CA3096458A1 (en) | 2018-04-12 | 2019-10-17 | Umoja Biopharma, Inc. | Viral vectors and packaging cell lines |
| CN115210252A (zh) | 2020-02-04 | 2022-10-18 | 西雅图儿童医院（Dba西雅图儿童研究所） | 抗二硝基苯酚的嵌合抗原受体 |
| AU2021231887A1 (en) * | 2020-03-06 | 2022-10-20 | Purdue Research Foundation | Methods, compounds, and compositions for modifying CAR-T cell activity |
| CN116096861A (zh) * | 2020-04-03 | 2023-05-09 | 赛立维公司 | 过继性细胞转移的增强 |
| AU2021386252A1 (en) * | 2020-11-30 | 2023-06-29 | Purdue Research Foundation | Combinations of small molecule drug conjugate and car-expressing cytotoxic lymphocytes and methods of treating cancer using the same |
| CN118139627A (zh) * | 2021-08-30 | 2024-06-04 | 普渡研究基金会 | 使car t细胞恢复活力的缀合物、组合物和方法 |
| JP2025506652A (ja) * | 2022-02-18 | 2025-03-13 | エフ． ホフマン－ラ ロシュ アーゲー | 試料中の目的の分析物を検出するための方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010536341A (ja) * | 2007-08-15 | 2010-12-02 | アムニクス， インコーポレイテッド | 生物学的に活性なポリペプチドの特性を改変するための組成物および方法 |
| CN105829349B (zh) * | 2013-10-15 | 2023-02-03 | 斯克利普斯研究所 | 肽嵌合抗原受体t细胞开关和其用途 |
| CN105814083A (zh) * | 2013-10-15 | 2016-07-27 | 加州生物医学研究所 | 嵌合抗原受体t细胞开关和其用途 |
| ES2918501T3 (es) * | 2013-12-19 | 2022-07-18 | Novartis Ag | Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos |
| WO2015092024A2 (en) * | 2013-12-20 | 2015-06-25 | Cellectis | Method of engineering multi-input signal sensitive t cell for immunotherapy |
| US20170335281A1 (en) * | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| CA2945388A1 (en) * | 2014-04-23 | 2015-10-29 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) for use in therapy and methods for making the same |
| US20180243340A1 (en) * | 2015-08-24 | 2018-08-30 | University Of Houston System | Combination therapy combining car + t cells with appropriately timed immunodulatory antibodies |
| US20190161530A1 (en) * | 2016-04-07 | 2019-05-30 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
| EP3439675A4 (en) * | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| AU2017271550B2 (en) * | 2016-05-25 | 2023-11-02 | Endocyte, Inc. | Method of treating cancer by targeting myeloid-derived suppressor cells |
| CN116474108A (zh) * | 2016-12-14 | 2023-07-25 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 |
| CA3053534A1 (en) * | 2017-02-17 | 2018-08-23 | Purdue Research Foundation | Targeted ligand-payload based drug delivery for cell therapy |
-
2019
- 2019-07-21 CN CN201980052586.7A patent/CN112543651B/zh active Active
- 2019-07-21 WO PCT/US2019/042726 patent/WO2020033129A1/en not_active Ceased
- 2019-07-21 US US17/266,509 patent/US20210308267A1/en not_active Abandoned
- 2019-07-21 SG SG11202100616VA patent/SG11202100616VA/en unknown
- 2019-07-21 CA CA3108710A patent/CA3108710A1/en active Pending
- 2019-07-21 JP JP2021506492A patent/JP7623935B2/ja active Active
- 2019-07-21 AU AU2019317278A patent/AU2019317278B2/en active Active
- 2019-07-21 EP EP19847190.6A patent/EP3833400A4/en active Pending
- 2019-07-21 KR KR1020217006445A patent/KR20210042125A/ko not_active Ceased
- 2019-07-21 CN CN202310525133.XA patent/CN116763943A/zh active Pending
-
2023
- 2023-12-21 US US18/392,939 patent/US20240148880A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533166A5 (enExample) | ||
| US20220146513A1 (en) | Methods for detecting peptide/mhc/tcr binding | |
| Becker et al. | Biogenesis of mitochondria: dual role of Tom7 in modulating assembly of the preprotein translocase of the outer membrane | |
| Rubino et al. | Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes | |
| Ray et al. | Mechanism of active renal tubular efflux of tenofovir | |
| JP2017513524A5 (enExample) | ||
| Malheiro et al. | Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation | |
| Seethala et al. | Handbook of drug screening | |
| Celedon et al. | Stoichiometry for binding and transport by the twin arginine translocation system | |
| Zeitler et al. | The FG-repeat asymmetry of the nuclear pore complex is dispensable for bulk nucleocytoplasmic transport in vivo | |
| Black et al. | NXT1 is necessary for the terminal step of Crm1-mediated nuclear export | |
| WO2005116072A3 (en) | Antibodies as t cell receptor mimics, methods of production and uses thereof | |
| WO2008054517A3 (en) | Immunosuppressant binding antibodies and methods of obtaining and using same | |
| JP2017514481A5 (enExample) | ||
| JP2006502416A5 (enExample) | ||
| Glander et al. | Inosine 5′-monophosphate dehydrogenase activity as a biomarker in the field of transplantation | |
| Schnell | Shedding light on the chloroplast protein import machinery | |
| Aukrust et al. | Post‐translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes | |
| Adam et al. | Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis | |
| Giri et al. | CXCL12‐induced partitioning of flotillin‐1 with lipid rafts plays a role in CXCR4 function | |
| Creighton et al. | Adenosine monophosphate-activated kinase α1 promotes endothelial barrier repair | |
| EP2180323A1 (en) | Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin A complexes in a blood sample | |
| Dirscherl et al. | A two-hybrid antibody micropattern assay reveals specific in cis interactions of MHC I heavy chains at the cell surface | |
| Conor Moran et al. | Mitoribosome biogenesis | |
| JP2007528502A5 (ja) | エベロリムスの測定方法および測定キット |